ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Translational and Clinical Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1689305
This article is part of the Research TopicHormonal responses in women across the lifespan and their impact on physical performanceView all 3 articles
Fluctuations and interrelationship of oxidative stress and hepcidin during the menstrual cycle
Provisionally accepted- 1Graduate School of Sport Sciences, Waseda University, Tokorozawa, Japan
- 2Faculty of Sport Sciences, Toin University of Yokohama, Yokohama, Japan
- 3Faculty of Biomedical Engineering, Toin University of Yokohama, Yokohama, Japan
- 4Institute for Biomedicine and Glycomics, Griffith University, Brisbane, Australia
- 5Faculty of Sport Sciences, Waseda University, Tokorozawa, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Menstruation is a daily opportunity for iron loss in women. Hepcidin (Hepc), a key regulator of iron metabolism, is known to respond to both iron status and inflammation. Menstruation is also accompanied by local and systemic production of reactive oxygen species and inflammatory responses. However, fluctuations in Hepc and oxidative stress during the menstrual cycle and their relationship are unclear. The purpose of this study was to clarify of the fluctuations Hepc and oxidative stress and relationships. Methods: Sixteen women were recruited, of whom twelve with normal menstrual cycles were included in the final analysis. Blood samples were collected at four time points — The menstrual phase (MP), follicular phase (FP), early luteal phase (ELP), and late luteal phase (LLP) — while the participants were at rest. Serum Hepc, serum ferritin (FER), and oxidative stress levels were evaluated. In addition, differences between the iron-deficient (ID, <12 ng/ml) and non–iron-deficient (NID, ≥12 ng/ml) groups, classified according to FER levels during the ELP, were examined. Results: Oxidative stress showed significant fluctuations across the menstrual cycle (p < 0.01), with higher values during the MP and FP compared with the LLP. This trend was particularly pronounced in the ID group. Hepc did not exhibit significant cyclical fluctuations. Nevertheless, its mean level was highest in the MP and lowest in the FP. No significant correlation was observed between oxidative stress and Hepc. FER was positively correlated with Hepc only in the LP (r = 0.769, p = 0.043), and significant differences in Hepc levels between the ID and NID groups were observed exclusively in the ELP (p = 0.003) and LLP (p = 0.010). Conclusion: Oxidative stress fluctuated across the menstrual cycle, with increases observed during the MP and FP. These fluctuations appeared to be more pronounced in the presence of ID. In contrast, Hepc did not exhibit consistent cyclical changes. Although oxidative stress was considered to influence Hepc elevation through inflammatory responses, no direct relationship was detected at the blood marker level.
Keywords: oxidative stress1, Menstrual Cycle2, Iron metabolism3, Hepcidin4, Iron deficiency5, d-ROMs6
Received: 20 Aug 2025; Accepted: 10 Oct 2025.
Copyright: © 2025 Yoshida, Hayashida, Shimizu, Cox and Suzuki. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Katsuhiko Suzuki, katsu.suzu@waseda.jp
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.